Microtome Market Report Scope & Overview:

The Microtome Market size was estimated at USD 428.0 Million in 2022 and is expected to reach USD 724.4 Million by 2030 with a growing CAGR of 6.8% over the forecast period of 2023 to 2030.

It is primarily driven by the increased prevalence of chronic illnesses, an ageing population, and rising healthcare costs, particularly in industrialised nations. One of the primary elements expected to enhance development is the increasing commercial availability of high-quality diagnostic technology in developed nations, which accounts for the majority of revenue. Nonetheless, there remains an unmet need for technologically advanced diagnostic equipment in poor countries due to lower per capita disposable income and limited commercial availability. A microtome is an instrument used to cut tiny slices from plant or animal tissue samples. Depending on the type of specimen and the necessary thickness, the tool employs unique blades made of metal, glass, or diamond.

Microtome Market Revenue Analysis

To Get More Information on Microtome Market - Request Sample Report

The market is being driven by increased knowledge about the early detection of different chronic illnesses as well as the advent of technologically enhanced diagnostic equipment and pathology systems. Furthermore, an increase in the prevalence of chronic diseases such as cancer, along with an increase in the elderly population, drives market expansion. However, an unfavourable reimbursement condition limits market expansion.



  • Chronic disease prevalence is increasing, technological advancements

The rising prevalence of chronic illnesses like cancer and cardiovascular disease raises the demand for histopathology tests. Microtomes are important in preparing tissue samples for precise diagnosis, which contributes to market growth. Continuous improvements in microtome technology, such as automated and digital microtomes, increase tissue sectioning precision, efficiency, and convenience of use. These technical advancements boost acceptance and market expansion.


  • The high expense of sophisticated microtomes as well as the availability of alternative approaches.


  • Emerging markets, digital pathology integration.

Growing healthcare infrastructure and increased investment in medical facilities in emerging nations provide considerable market expansion potential. These areas frequently have a growing demand for histopathology, which might encourage the use of microtomes. Microtomes integrated with digital pathology systems allow for quick image interpretation, remote consultation, and data administration. As digital pathology becomes more popular, microtome manufacturers will have more opportunity to combine their technologies and provide full solutions.


  • Lack of skilled professionals

  • Reimbursement challenges


Reduced healthcare spending Conflicts can put national economies under strain, diverting funding away from healthcare budgets. Reduced healthcare funding may hinder the purchase of new medical equipment, such as microtomes. Laboratories may prioritise expenditure on key equipment and supplies while deferring or cutting back on non-essential equipment improvements.

During times of conflict and insecurity, research emphasis may shift towards solving acute health concerns and emergency care. Basic research and non-essential diagnoses, such as histopathology studies using microtomes, may be given less attention and money. Uncertainty in the market in conflict's geopolitical instability may cause customers, notably healthcare institutions and laboratories, to be wary. Uncertainty about the future and prospective geopolitical changes might cause investors to be hesitant to make long-term investments, thereby affecting the microtome industry.


Price competition Healthcare organisations and institutions may become more price-sensitive during an economic crisis. They may seek cost reductions and negotiate pricing with vendors, including microtome makers. Manufacturers may be under additional pressure to provide competitive prices or discounts in order to retain customers and obtain new orders. Market concentration and consolidation Economic downturns can cause industry consolidation as businesses attempt to cut costs and enhance efficiency. This may result in mergers, acquisitions, or closures of smaller producers or distributors in the microtome business, resulting in market concentration among bigger competitors. During a recession, healthcare organisations may prioritise spending on vital medical equipment and supplies while decreasing spending on non-essential goods.


By Product

  • Microtome Devices

  • Rotary Microtome

  • Vibrating Microtome

  • Other Microtome

  • Accessories

By Technology

  • Fully Automated

  • Semiautomated

  • Manual

Microtome Market Segmentation Analysis

Do You Need any Customization Research on Microtome Market - Enquire Now


North America

  • US

  • Canada

  • Mexico


  • Eastern Europe

    • Poland

    • Romania

    • Hungary

    • Turkey

    • Rest of Eastern Europe

  • Western Europe

    • Germany

    • France

    • UK

    • Italy

    • Spain

    • Netherlands

    • Switzerland

    • Austria

    • Rest of Western Europe

Asia Pacific

  • China

  • India

  • Japan

  • South Korea

  • Vietnam

  • Singapore

  • Australia

  • Rest of Asia Pacific

Middle East & Africa

  • Middle East

    • UAE

    • Egypt

    • Saudi Arabia

    • Qatar

    • Rest of Middle East

  • Africa

    • Nigeria

    • South Africa

    • Rest of Africa

Latin America

  • Brazil

  • Argentina

  • Colombia

  • Rest of Latin America


North America held the biggest market share of 50.1% due to improved healthcare infrastructure, increased public and private sector expenditures in in vitro diagnostics, the existence of a large number of market participants, and the adoption of technologically sophisticated products. Furthermore, the rising frequency of cancer in North America is increasing demand for biopsies, resulting in increased demand.

Over the next several years, Asia-Pacific is predicted to be the fastest-growing area. This region is expected to increase dramatically as per capita income rises, the medical tourism business expands, and public awareness of the benefits of early detection grows. In comparison to Japan, China is expected to expand quicker in the Asia-Pacific area.

Key Players

The major players are LLS ROWIAK LaserLabSolutions GmbH, Leica Biosystems Nussloch GmbH, Sakura, MEDITE GmbH, SLEE medical GmbH, Boeckeler Instruments, Nanolytik, S.M. Scientific Instruments Pvt. Ltd, MICROS Austria Produktions-und Handelsges.m.b.H, AGD Biomedicals (P) Ltd,.and others

Biosystems Nussloch GmbH-Company Financial Analysis

Company Landscape Analysis


Myriad Genetics: In June 2023, Myriad Genetics, Inc., a genetic testing and precision medicine firm located in Salt Lake City, Utah, unveiled new research and expanded its Precise Oncology Solutions portfolio at the American Society of Clinical Oncology (ASCO) in 2023.

F. Hoffmann-La Roche Ltd: In March 2023, F. Hoffmann-La Roche Ltd (Roche), a biotechnology company that develops drugs and vaccines and diagnostics for serious illnesses, announced a cooperation with Eli Lilly and Company, a pharmaceutical business located in the United States, to boost the development of Roche's Elecsys Microtomes.

Microtome Market Report Scope:

Report Attributes Details
Market Size in 2022  US$ 428.0 Mn
Market Size by 2030  US$ 724.4 Mn
CAGR   CAGR of 6.8 % From 2023 to 2030
Base Year  2022
Forecast Period  2023-2030
Historical Data  2020-2021
Report Scope & Coverage Market Size, Segments Analysis, Competitive  Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook
Key Segments • By Product (Microtome Devices, Rotary Microtome, Vibrating Microtome, Other Microtome, Accessories)
• By Technology (Fully Automated, Semiautomated, Manual)
Regional Analysis/Coverage North America (US, Canada, Mexico), Europe (Eastern Europe [Poland, Romania, Hungary, Turkey, Rest of Eastern Europe] Western Europe] Germany, France, UK, Italy, Spain, Netherlands, Switzerland, Austria, Rest of Western Europe]). Asia Pacific (China, India, Japan, South Korea, Vietnam, Singapore, Australia, Rest of Asia Pacific), Middle East & Africa (Middle East [UAE, Egypt, Saudi Arabia, Qatar, Rest of Middle East], Africa [Nigeria, South Africa, Rest of Africa], Latin America (Brazil, Argentina, Colombia Rest of Latin America)
Company Profiles LLS ROWIAK LaserLabSolutions GmbH; Leica Biosystems Nussloch GmbH; Sakura; MEDITE GmbH; SLEE medical GmbH; Boeckeler Instruments; Nanolytik; S.M. Scientific Instruments Pvt. Ltd.; MICROS Austria Produktions-und Handelsges.m.b.H; AGD Biomedicals (P) Ltd
Key Drivers • Chronic disease prevalence is increasing, technological advancements
Market Restraints • The high expense of sophisticated microtomes as well as the availability of alternative approaches.


Frequently Asked Questions

Ans: Microtome Market is anticipated to expand by 6.8% from 2023 to 2030.

Ans:  USD 724.4 Million is expected to grow by 2030.

Ans: Microtome Market size was valued at USD 428.0 Million in 2022

Ans: North America is dominating the market.

Ans: Lack of skilled professionals and Reimbursement challenges


1. Introduction
1.1 Market Definition
1.2 Scope
1.3 Research Assumptions

2. Research Methodology

3. Market Dynamics
3.1 Drivers
3.2 Restraints
3.3 Opportunities
3.4 Challenges

4. Impact Analysis
4.1 Impact of the Russia-Ukraine War
4.2 Impact of Ongoing Recession
4.2.1 Introduction
4.2.2 Impact on major economies US Canada Germany France United Kingdom China Japan South Korea Rest of the World

5. Value Chain Analysis

6. Porter’s 5 forces model

7. PEST Analysis

8. Microtome Market Segmentation, By Product
8.1 Microtome Devices
8.2 Rotary Microtome
8.3 Vibrating Microtome
8.4 Other Microtome
8.5 Accessories

9. Microtome Market Segmentation, By Technology
9.1 Fully Automated
9.2 Semiautomated
9.3 Manual

10. Regional Analysis
10.1 Introduction
10.2 North America
10.2.1 North America Microtome Market by Country
10.2.2North America Microtome Market by Product
10.2.3 North America Microtome Market by Technology
10.2.4 USA USA Microtome Market by Product USA Microtome Market by Technology
10.2.5 Canada Canada Microtome Market by Product Canada Microtome Market by Technology
10.2.6 Mexico Mexico Microtome Market by Product Mexico Microtome Market by Technology
10.3 Europe
10.3.1 Eastern Europe Eastern Europe Microtome Market by Country Eastern Europe Microtome Market by Product Eastern Europe Microtome Market by Technology Poland Poland Microtome Market by Product Poland Microtome Market by Technology Romania Romania Microtome Market by Product Romania Microtome Market by Technology Hungary Hungary Microtome Market by Product Hungary Microtome Market by Technology Turkey Turkey Microtome Market by Product Turkey Microtome Market by Technology Rest of Eastern Europe Rest of Eastern Europe Microtome Market by Product Rest of Eastern Europe Microtome Market by Technology
10.3.2 Western Europe Western Europe Microtome Market by Country Western Europe Microtome Market by Product Western Europe Microtome Market by Technology Germany Germany Microtome Market by Product Germany Microtome Market by Technology France France Microtome Market by Product France Microtome Market by Technology UK UK Microtome Market by Product UK Microtome Market by Technology Italy Italy Microtome Market by Product Italy Microtome Market by Technology Spain Spain Microtome Market by Product Spain Microtome Market by Technology Netherlands Netherlands Microtome Market by Product Netherlands Microtome Market by Technology Switzerland Switzerland Microtome Market by Product Switzerland Microtome Market by Technology Austria Austria Microtome Market by Product Austria Microtome Market by Technology Rest of Western Europe Rest of Western Europe Microtome Market by Product Rest of Western Europe Microtome Market by Technology
10.4 Asia-Pacific
10.4.1 Asia Pacific Microtome Market by Country
10.4.2 Asia Pacific Microtome Market by Product
10.4.3 Asia Pacific Microtome Market by Technology
10.4.4 China China Microtome Market by Product China Microtome Market by Technology
10.4.5 India India Microtome Market by Product India Microtome Market by Technology
10.4.6 Japan Japan Microtome Market by Product Japan Microtome Market by Technology
10.4.7 South Korea South Korea Microtome Market by Product South Korea Microtome Market by Technology
10.4.8 Vietnam Vietnam Microtome Market by Product Vietnam Microtome Market by Technology
10.4.9 Singapore Singapore Microtome Market by Product Singapore Microtome Market by Technology
10.4.10 Australia Australia Microtome Market by Product Australia Microtome Market by Technology
10.4.11 Rest of Asia-Pacific Rest of Asia-Pacific Microtome Market by Product Rest of Asia-Pacific Microtome Market by Technology
10.5 Middle East & Africa
10.5.1 Middle East Middle East Microtome Market by Country Middle East Microtome Market by Product Middle East Microtome Market by Technology UAE UAE Microtome Market by Product UAE Microtome Market by Technology Egypt Egypt Microtome Market by Product Egypt Microtome Market by Technology Saudi Arabia Saudi Arabia Microtome Market by Product Saudi Arabia Microtome Market by Technology Qatar Qatar Microtome Market by Product Qatar Microtome Market by Technology Rest of Middle East Rest of Middle East Microtome Market by Product Rest of Middle East Microtome Market by Technology
10.5.2 Africa Africa Microtome Market by Country Africa Microtome Market by Product Africa Microtome Market by Technology Nigeria Nigeria Microtome Market by Product Nigeria Microtome Market by Technology South Africa South Africa Microtome Market by Product South Africa Microtome Market by Technology Rest of Africa Rest of Africa Microtome Market by Product Rest of Africa Microtome Market by Technology
10.6 Latin America
10.6.1 Latin America Microtome Market by Country
10.6.2 Latin America Microtome Market by Product
10.6.3 Latin America Microtome Market by Technology
10.6.4 Brazil Brazil Microtome Market by Product Brazil Africa Microtome Market by Technology
10.6.5 Argentina Argentina Microtome Market by Product Argentina Microtome Market by Technology
10.6.6 Colombia Colombia Microtome Market by Product Colombia Microtome Market by Technology
10.6.7 Rest of Latin America Rest of Latin America Microtome Market by Product Rest of Latin America Microtome Market by Technology

11. Company Profile
11.1 LLS ROWIAK LaserLabSolutions GmbH
11.1.1 Company Overview
11.1.2 Financials
11.1.3 Product/Services Offered
11.1.4 SWOT Analysis
11.1.5 The SNS View
11.2 Leica Biosystems Nussloch GmbH
11.2.1 Company Overview
11.2.2 Financials
11.2.3 Product/Services Offered
11.2.4 SWOT Analysis
11.2.5 The SNS View
11.3 Sakura
11.3.1 Company Overview
11.3.2 Financials
11.3.3 Product/Services Offered
11.3.4 SWOT Analysis
11.3.5 The SNS View
11.4 MEDITE GmbH
11.4 Company Overview
11.4.2 Financials
11.4.3 Product/Services Offered
11.4.4 SWOT Analysis
11.4.5 The SNS View
11.5 SLEE Medical GmbH
11.5.1 Company Overview
11.5.2 Financials
11.5.3 Product/Services Offered
11.5.4 SWOT Analysis
11.5.5 The SNS View
11.6 Boeckeler Instruments
11.6.1 Company Overview
11.6.2 Financials
11.6.3 Product/Services Offered
11.6.4 SWOT Analysis
11.6.5 The SNS View
11.7 Nanolytik
11.7.1 Company Overview
11.7.2 Financials
11.7.3 Product/Services Offered
11.7.4 SWOT Analysis
11.7.5 The SNS View
11.8 S.M. Scientific Instruments Pvt. Ltd
11.8.1 Company Overview
11.8.2 Financials
11.8.3 Product/Services Offered
11.8.4 SWOT Analysis
11.8.5 The SNS View
11.9 MICROS Austria Produktions-und Handelsges.m.b.H
11.9.1 Company Overview
11.9.2 Financials
11.9.3 Product/ Services Offered
11.9.4 SWOT Analysis
11.9.5 The SNS View
11.10 AGD Biomedicals (P) Ltd
11.10.1 Company Overview
11.10.2 Financials
11.10.3 Product/Services Offered
11.10.4 SWOT Analysis
11.10.5 The SNS View

12. Competitive Landscape
12.1 Competitive Benchmarking
12.2 Market Share Analysis
12.3 Recent Developments
12.3.1 Industry News
12.3.2 Company News
12.3.3 Mergers & Acquisitions

13. USE Cases and Best Practices

14. Conclusion

An accurate research report requires proper strategizing as well as implementation. There are multiple factors involved in the completion of good and accurate research report and selecting the best methodology to compete the research is the toughest part. Since the research reports we provide play a crucial role in any company’s decision-making process, therefore we at SNS Insider always believe that we should choose the best method which gives us results closer to reality. This allows us to reach at a stage wherein we can provide our clients best and accurate investment to output ratio.

Each report that we prepare takes a timeframe of 350-400 business hours for production. Starting from the selection of titles through a couple of in-depth brain storming session to the final QC process before uploading our titles on our website we dedicate around 350 working hours. The titles are selected based on their current market cap and the foreseen CAGR and growth.


The 5 steps process:

Step 1: Secondary Research:

Secondary Research or Desk Research is as the name suggests is a research process wherein, we collect data through the readily available information. In this process we use various paid and unpaid databases which our team has access to and gather data through the same. This includes examining of listed companies’ annual reports, Journals, SEC filling etc. Apart from this our team has access to various associations across the globe across different industries. Lastly, we have exchange relationships with various university as well as individual libraries.

Secondary Research

Step 2: Primary Research

When we talk about primary research, it is a type of study in which the researchers collect relevant data samples directly, rather than relying on previously collected data.  This type of research is focused on gaining content specific facts that can be sued to solve specific problems. Since the collected data is fresh and first hand therefore it makes the study more accurate and genuine.

We at SNS Insider have divided Primary Research into 2 parts.

Part 1 wherein we interview the KOLs of major players as well as the upcoming ones across various geographic regions. This allows us to have their view over the market scenario and acts as an important tool to come closer to the accurate market numbers. As many as 45 paid and unpaid primary interviews are taken from both the demand and supply side of the industry to make sure we land at an accurate judgement and analysis of the market.

This step involves the triangulation of data wherein our team analyses the interview transcripts, online survey responses and observation of on filed participants. The below mentioned chart should give a better understanding of the part 1 of the primary interview.

Primary Research

Part 2: In this part of primary research the data collected via secondary research and the part 1 of the primary research is validated with the interviews from individual consultants and subject matter experts.

Consultants are those set of people who have at least 12 years of experience and expertise within the industry whereas Subject Matter Experts are those with at least 15 years of experience behind their back within the same space. The data with the help of two main processes i.e., FGDs (Focused Group Discussions) and IDs (Individual Discussions). This gives us a 3rd party nonbiased primary view of the market scenario making it a more dependable one while collation of the data pointers.

Step 3: Data Bank Validation

Once all the information is collected via primary and secondary sources, we run that information for data validation. At our intelligence centre our research heads track a lot of information related to the market which includes the quarterly reports, the daily stock prices, and other relevant information. Our data bank server gets updated every fortnight and that is how the information which we collected using our primary and secondary information is revalidated in real time.

Data Bank Validation

Step 4: QA/QC Process

After all the data collection and validation our team does a final level of quality check and quality assurance to get rid of any unwanted or undesired mistakes. This might include but not limited to getting rid of the any typos, duplication of numbers or missing of any important information. The people involved in this process include technical content writers, research heads and graphics people. Once this process is completed the title gets uploader on our platform for our clients to read it.

Step 5: Final QC/QA Process:

This is the last process and comes when the client has ordered the study. In this process a final QA/QC is done before the study is emailed to the client. Since we believe in giving our clients a good experience of our research studies, therefore, to make sure that we do not lack at our end in any way humanly possible we do a final round of quality check and then dispatch the study to the client.

  •            5000 (33% Discount)

  •            8950 (40% Discount)

  •            3050 (23% Discount)

Start a Conversation

Hi! Click one of our member below to chat on Phone